Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Review

PAD screening: why? whom? when? how? – a systematic review

Published Online:July 17, 2020https://doi.org/10.1024/0301-1526/a000897

Abstract

Summary: An estimated 237 million people suffer from peripheral arterial disease (PAD), which is associated with high morbidity and mortality, and prevalence is still increasing. Currently, we do not have any randomized trials that compare screening to no screening specifically for PAD in the general population. Presently, PAD screening is not generally established. This systematic review gives an overview of relevant literature and guidelines. Screening usually focuses on ankle-brachial index (ABI)-measurement, which enables detection of asymptomatic and symptomatic PAD, but has limitations in diabetics. There are no sufficient data on PAD screening. Guideline recommendations are heterogeneous. While some advocate no screening until better data are available, most recommend selective screening despite insufficient data on morbidity and mortality reduction in consequence of screening. We support the only evidence-based screening strategy for PAD: combined screening for abdominal aortic aneurysm (AAA), PAD and arterial hypertension in men aged 65–74 according to the VIVA study. We additionally suggest a new simple three-step screening strategy for symptomatic PAD in all individuals aged 40 and older, who see a general practitioner: Asking one question (“Do you have pain or cramps in the legs during normal walking?”) followed by physical examination (normal lower extremity pulse status?) in those, whose answer is “yes”, and ABI measurement unless all pulses are normal.

References

  • 1 Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–30. First citation in articleCrossref Medline, Google Scholar

  • 2 Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. First citation in articleCrossref Medline, Google Scholar

  • 3 Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24. First citation in articleCrossref Medline, Google Scholar

  • 4 Diehm C, Lange S, Darius H, Pittrow D, Von Stritzky B, Tepohl G, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27(14):1743–9. First citation in articleCrossref Medline, Google Scholar

  • 5 Soejima H, Morimoto T, Saito Y, Ogawa H. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials. Thromb Haemost. 2010;104(6):1085–8. First citation in articleMedline, Google Scholar

  • 6 Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: An international, randomised, double-blind, placebo-controlled trial. Lancet. 2017. First citation in articleGoogle Scholar

  • 7 Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020. First citation in articleCrossref Medline, Google Scholar

  • 8 Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645–54. First citation in articleCrossref Medline, Google Scholar

  • 9 Dopheide JF, Veit J, Ramadani H, Adam L, Papac L, Vonbank A, et al. Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother. 2019. First citation in articleCrossref Medline, Google Scholar

  • 10 Lindholt JS, Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): A randomised controlled trial. Lancet. 2017;390(10109):2256–65. First citation in articleCrossref Medline, Google Scholar

  • 11 Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968. Available from: https://apps.who.int/iris/handle/10665/37650. First citation in articleGoogle Scholar

  • 12 Kieback AG, Lorbeer R, Wallaschofski H, Ittermann T, Volzke H, Felix S, et al. Claudication, in contrast to angina pectoris, independently predicts mortality risk in the general population. Vasa. 2012;41(2):105–13. First citation in articleLink, Google Scholar

  • 13 Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes – A review. Diabet Med. 2010;27(1):4–14. First citation in articleCrossref Medline, Google Scholar

  • 14 Ramos R, Baena-Diez JM, Quesada M, Solanas P, Subirana I, Sala J, et al. Derivation and validation of REASON: A risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index. Atherosclerosis. 2011;214(2):474–9. First citation in articleCrossref Medline, Google Scholar

  • 15 Kieback AG, Espinola-Klein C, Lamina C, Moebus S, Tiller D, Lorbeer R, et al. One simple claudication question as first step in Peripheral Arterial Disease (PAD) screening: A meta-analysis of the association with reduced Ankle Brachial Index (ABI) in 27,945 subjects. PLoS One. 2019;14(11):e0224608. First citation in articleCrossref Medline, Google Scholar

  • 16 Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–58. First citation in articleMedline, Google Scholar

  • 17 Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: An improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45(10):1101–9. First citation in articleCrossref Medline, Google Scholar

  • 18 Bell AD, Roussin A, Popovici-Toma D, Girard M, Chiu JF, Huckell V. The value of routine screening for peripheral arterial disease in stable outpatients with a history of coronary artery or cerebrovascular disease. Int J Clin Pract. 2013;67(10):996–1004. First citation in articleCrossref Medline, Google Scholar

  • 19 Londero LS, Lindholt JS, Thomsen MD, Hoegh A. Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease. J Vasc Surg. 2016;63(5):1305–10. First citation in articleCrossref Medline, Google Scholar

  • 20 Kaufmann C, Jacomella V, Kovacicova L, Husmann M, Clemens RK, Thalhammer C, et al. Predictive value of auscultation of femoropopliteal arteries. Swiss Med Wkly. 2013;143:w13761. First citation in articleMedline, Google Scholar

  • 21 Xu D, Zou L, Xing Y, Hou L, Wei Y, Zhang J, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol. 2013;29(4):492–8. First citation in articleCrossref Medline, Google Scholar

  • 22 Schroder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, et al. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc Surg. 2006;44(3):531–6. First citation in articleCrossref Medline, Google Scholar

  • 23 Espinola-Klein C, Rupprecht HJ, Bickel C, Lackner K, Savvidis S, Messow CM, et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation. 2008;118(9):961–7. First citation in articleCrossref Medline, Google Scholar

  • 24 Zhan Y, Zhuang J, Dong Y, Xu H, Hu D, Yu J. Predicting the prevalence of peripheral arterial diseases: Modelling and validation in different cohorts. Vasa. 2016;45(1):31–6. First citation in articleLink, Google Scholar

  • 25 Lin JS, Olson CM, Johnson ES, Whitlock EP. The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159(5):333–41. First citation in articleCrossref Medline, Google Scholar

  • 26 Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(Suppl 3):42S–53S. First citation in articleCrossref Medline, Google Scholar

  • 27 Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S, et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study. Int J Cardiol. 2018;254:36–42. First citation in articleCrossref Medline, Google Scholar

  • 28 Harrison ML, Lin HF, Blakely DW, Tanaka H. Preliminary assessment of an automatic screening device for peripheral arterial disease using ankle-brachial and toe-brachial indices. Blood Press Monit. 2011;16(3):138–41. First citation in articleCrossref Medline, Google Scholar

  • 29 Fores R, Alzamora MT, Pera G, Toran P, Urrea M, Heras A. Concordance between 3 methods of measurement the ankle-brachial index to diagnose peripheral artery disease. Med Clin (Barc). 2014;143(8):335–40. First citation in articleMedline, Google Scholar

  • 30 Wohlfahrt P, Ingrischova M, Krajcoviechova A, Palous D, Dolejsova M, Seidlerova J, et al. A novel oscillometric device for peripheral arterial disease screening in everyday practice. The Czech-post MONICA study. Int Angiol. 2011;30(3):256–61. First citation in articleMedline, Google Scholar

  • 31 Hoyer C, Hogh AL, Sandermann J, Zacho HD, Petersen LJ. Risk factors and haemodynamic variables in patients with low toe-brachial index but normal ankle-brachial index. Atherosclerosis. 2019;289:21–6. First citation in articleCrossref Medline, Google Scholar

  • 32 Eiberg JP, Gronvall Rasmussen JB, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg. 2010;40(4):507–12. First citation in articleCrossref Medline, Google Scholar

  • 33 Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, Katsanos K, et al. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2020;36(Suppl 1):e3277. First citation in articleMedline, Google Scholar

  • 34 Kayhan A, Palabiyik F, Serinsoz S, Kiris A, Bayramoglu S, Williams JT, et al. Multidetector CT angiography versus arterial duplex USG in diagnosis of mild lower extremity peripheral arterial disease: Is multidetector CT a valuable screening tool? Eur J Radiol. 2012;81(3):542–6. First citation in articleCrossref Medline, Google Scholar

  • 35 Hansen TB, Sogaard R, Lindholt JS. Pharmacological preventive potential among attenders at vascular screening: Findings from the VIVA trial. Eur J Vasc Endovasc Surg. 2020. First citation in articleCrossref, Google Scholar

  • 36 Diederichsen AC, Rasmussen LM, Sogaard R, Lambrechtsen J, Steffensen FH, Frost L, et al. The Danish Cardiovascular Screening Trial (DANCAVAS): Study protocol for a randomized controlled trial. Trials. 2015;16:554. First citation in articleCrossref Medline, Google Scholar

  • 37 Lindholt JS, Diederichsen AC, Rasmussen LM, Frost L, Steffensen FH, Lambrechtsen J, et al. Survival, prevalence, progression and repair of abdominal aortic aneurysms: Results from three randomised controlled screening trials over three decades. Clin Epidemiol. 2020;12:95–103. First citation in articleCrossref Medline, Google Scholar

  • 38 Heidrich H, Wenk R, Hesse P. Frequency of asymptomatic peripheral arterial disease in patients entering the department of general and internal medicine of a general-care hospital. Vasa. 2004;33(2):63–7. First citation in articleLink, Google Scholar

  • 39 Itoga NK, Minami HR, Chelvakumar M, Pearson K, Mell MM, Bendavid E, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med. 2018;23(2):97–106. First citation in articleCrossref Medline, Google Scholar

  • 40 Sogaard R, Lindholt JS. Cost-effectiveness of population-based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial. Br J Surg. 2018;105(10):1283–93. First citation in articleCrossref Medline, Google Scholar

  • 41 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67. First citation in articleCrossref Medline, Google Scholar

  • 42 Lawall H, Huppert P, Espinola-Klein C, Zemmrich CS, Ruemenapf G. German guideline on the diagnosis and treatment of peripheral artery disease – A comprehensive update 2016. Vasa. 2017;46(2):79–86. First citation in articleLink, Google Scholar

  • 43 Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al. ESVM Guideline on peripheral arterial disease. Vasa. 2019;48(Suppl 102):1–79. First citation in articleLink, Google Scholar

  • 44 Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;69(11):e71–126. First citation in articleCrossref Medline, Google Scholar

  • 45 Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(Suppl 3):2S–41S. First citation in articleMedline, Google Scholar

  • 46 Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation. 1999;100(2):171–7. First citation in articleCrossref Medline, Google Scholar

  • 47 Aboyans V, Lacroix P, Postil A, Guilloux J, Rolle F, Cornu E, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2005;46(5):815–20. First citation in articleCrossref Medline, Google Scholar

  • 48 Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, et al. The influence of peripheral arterial disease on outcomes: A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006;48(8):1567–72. First citation in articleCrossref Medline, Google Scholar